Comparative 1D Blue-Native electrophoresis analysis of Plasmodium falciparum and human proteins associated with cytoadherence. by Wu, Yang et al.
Wu et al. Malar J  (2018) 17:293  
https://doi.org/10.1186/s12936-018-2445-8
RESEARCH
Comparative 1D Blue-Native 
electrophoresis analysis of Plasmodium 
falciparum and human proteins associated 
with cytoadherence
Yang Wu1,3, Simon C. Wagstaff1, Saeed A. Al‑Harthi2 and Alister G. Craig1* 
Abstract 
Background: To understand more about changes to the molecular components that occur when host endothelium 
interacts with Plasmodium falciparum‑infected erythrocytes, a combined technique of protein separation (1D Blue‑
Native electrophoresis) and mass spectrometry of infected erythrocytes with endothelial cells (EC) in a co‑culture 
system has been used.
Methods: Native proteins were extracted from co‑cultures and identified by mass spectrometry. Proteomic data 
from different parasite strains, either adhesion proficient (to endothelial cells) or non‑adherent, were analysed in 
parallel to reveal protein associations linked to cytoadherence. Informatic approaches were developed to facilitate this 
comparison.
Results: Blue‑Native gel separation and LC/MS/MS identification revealed major differences in samples produced 
from endothelial cell co‑culture with adherent and non‑adherent parasite strains. This approach enabled us to identify 
protein associations seen only with the adhesion proficient parasite strain.
Conclusions: The combination of proteomic and analytical approaches has identified differences between adherent 
and non‑adherent parasite lines in co‑culture with EC, providing potential candidates for complexes or associations 
formed during cytoadherence involved in cell structure, signalling and apoptosis.
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Background
Plasmodium falciparum is the deadliest of the six 
human-infecting malaria species and responsible for the 
majority of malaria-related deaths. A unique character-
istic of this species is its ability, in mature form infected 
erythrocytes (IE), to undergo a range of adhesive inter-
actions, such as the binding of IE with endothelial cells 
(EC) (cytoadherence), and the interaction of IE with non-
infected erythrocytes (rosetting) and with other IE (auto-
agglutination). The severe clinical manifestations caused 
by P. falciparum are thought to be mediated, at least in 
part, by sequestering IE and/or by rosetting between 
infected and uninfected red blood cells to form clumps in 
the microvasculature of major organs such as the brain, 
lung and kidney [1, 2]. The primary mechanism underly-
ing sequestration of the asexual-stage P. falciparum IE to 
EC is mediated by the diverse var gene products, P. falci-
parum erythrocyte membrane protein-1 (PfEMP1), that 
are displayed on the surface of IE and can bind to sev-
eral host proteins, although recently other variant surface 
protein families have been implicated in rosetting [3, 4].
Cytoadherence in P. falciparum is a complex process 
involving a range of host receptors interacting with the 
parasite-encoded proteins. Well-characterized host mol-
ecules include ICAM-1, CD36, EPCR and chondroitin 
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sulphate-A (CSA) binding to specific PfEMP-1 domains 
from the parasite [5]. Although several molecules have 
been characterized in terms of the expression patterns, 
gene organization and their involvement in cytoadher-
ence, the molecular mechanisms underlying how the par-
asite proteins are able to modulate the behaviour of host 
EC have not been solved. Many adhesion receptors have 
co-operative functions that contribute to strengthening 
cytoadherence, such as between ICAM-1 and CD36 or 
EPCR in mediating adherence of P. falciparum IE to cul-
tured human microvascular EC [6–8].
PfEMP1 is known to interact with several proteins, 
both parasite and host derived, in the knob complex at 
the surface of the infected erythrocyte. The cytoplasmic 
acidic terminal segment of PfEMP1 has been shown to 
interact with KAHRP [9, 10] and PHIST [11, 12] pro-
teins as well as erythrocyte cytoskeleton components, 
such as actin, spectrin and ankyrin. On the host side, a 
large number of endothelial complexes have been iden-
tified, many involved in ligand capture and signalling 
events, for example the angiopoietin/Tie2 system [13]. 
The large dynamic range in protein abundance and the 
complexity of both proteomes present a challenge for 
analysis of these interactions. This work has focused on 
sample preparation procedures to reduce sample com-
plexity and potentially to increase the detection of low-
abundance proteins. The first qualitative approach used 
metabolically-labelled IE co-cultured with non-labelled 
EC to visualize global changes to IE proteomes during 
co-culture. This was followed by identification of proteins 
and associated complexes from co-culture systems using 
Blue Native (BN) gel electrophoresis [14]. Changes in 
potential interacting partners formed during cytoadher-
ence were identified by computational analysis of the BN 
gel fractions from spatial comparisons of proteomic ‘hits’, 
based on the position of the band from the binding para-
site line sample compared with the corresponding band 
in the non-binding parasite line and the bands either side 
of this, to allow for slight misalignment of the two lanes 
on the BN gel.
Methods
Parasite culture
Plasmodium falciparum clones and isolates used in this 
study were C24 [15], ItG [16] and 3D7 [17]. C24 and 
3D7 bind to CD36 but not ICAM-1, whereas ItG binds 
strongly to both receptors. Parasites were cultured 
in  vitro in group  O+ human erythrocytes using previ-
ously described conditions [18]. Briefly, parasites were 
cultured in RPMI-1640 medium (supplemented with 
37.5 mM HEPES/7 mM d-glucose/6 mM NaOH/25 µg/
ml gentamicin sulphate/2  mM  l-glutamine/10% human 
serum) at a pH of 7.2 in a gas mixture of 96% nitrogen, 
3% carbon dioxide and 1% oxygen. To minimize the effect 
of antigenic switching in culture, a batch of stabilates was 
prepared from a post-selection culture and used for no 
more than 3  weeks. IE were synchronized by 5% sorbi-
tol treatment, the parasites used for co-culture studies 
were at 25–30 h after invasion; mature trophozoites were 
enriched by Plasmagel flotation.
Endothelial cells and co‑culture conditions
Pooled human umbilical vein endothelial cells (HUVEC) 
were obtained from Promocell (Heidelberg, Ger-
many). HUVEC cultures were maintained as previously 
described [19]. HUVEC cells were used as they have a 
similar repertoire of expression of receptors as brain 
endothelium, in particular having very low levels of CD36 
but, on stimulation with TNF, very high levels of ICAM-1. 
Briefly, HUVEC were grown in complete endothelial cell 
medium containing 2% fetal bovine serum (Promocell). 
Cells at passages five to six were used when they were 
confluent on 1% gelatin (Sigma, UK) coated flasks. For 2D 
gel analysis, EC were co-cultured with IE in the presence 
of TNF; for studies on protein complexes, TNF-activated 
EC were co-cultured with IE as previously described [20], 
with modifications. Briefly, HUVEC grown to conflu-
ence in 75  cm2 flasks were activated with TNF (0.5  ng/
ml) for 8  h at 37  °C. Before the co-culture experiment, 
TNF was removed and the HUVEC were washed twice 
with binding buffer (RPMI-1640 with HEPES modifica-
tion and 0.2% glucose, pH 7.2). An enriched (40% para-
sitaemia) mature-trophozoite IE suspension (25–30  h 
after invasion) was adjusted to 1% haematocrit in binding 
buffer (RPMI-1640 with HEPES modification and 0.2% 
glucose, pH 7.2) and applied to a mono-layer of TNF-
activated HUVEC, co-cultured for 30 min with agitation 
every 10 min. Un-bound IE were then washed off and the 
bound IE and EC further extracted and analysed. All par-
asite and EC cultures were regularly monitored for myco-
plasma using the Takara PCR mycoplasma detection kit 
(Clontech).
Metabolic labelling of IE and fluorography
The metabolic labelling of parasites has been described 
previously [21] used here with modifications. Briefly, 
IE grown to trophozoite stage (25–30  h after invasion) 
were enriched by Plasmagel flotation and adjusted to 
40% parasitaemia. The IE were washed with serum-free 
RPMI-1640 medium without methionine three times. 
In  vitro metabolic labelling was carried out in methio-
nine-free RPMI medium by the addition of 50  µCi/ml 
 [35S] methionine for 4  h under standard culture condi-
tions. The reaction was stopped by removing the radio-
isotope via centrifugation and washing with binding 
buffer. The labelled parasites were lysed with hypotonic 
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buffer [1/10 dilution of binding buffer with 1× protein-
ase inhibitor (cOmplete™, Mini, Roche, Germany)], then 
neutralized with binding buffer (1/10, v/v), centrifuged at 
3000×g for 10 min, the supernatant was used as the solu-
ble protein fraction, the pellet was used as the membrane 
fraction. The labelled parasites were also used intact in 
co-culture experiments. After co-culture, protein extrac-
tion was performed as described (see below) under dena-
turing conditions and subjected to 2D-electrophoresis. 
After electrophoresis, the gel was fixed and stained with 
Coomassie Blue, immersed in Amplify (Amersham) for 
30 min and dried for imaging.
Protein extraction under denaturing and native conditions
After 30  min of co-culture, unbound IE were washed 
off from EC using binding buffer 3–5 times, monitor-
ing binding levels under the microscope. C24 is a non-
adhesive strain to HUVEC while ItG is a strong binder, 
due to the dependence of adhesion on ICAM-1 in this 
system. For binding with intact IE, 1 ml hypotonic buffer 
was added and incubated for 30  s. For denaturing 2D 
electrophoresis, the lysis of IE was stopped by gently add-
ing 9 ml binding buffer. EC were washed once and excess 
liquid was removed. 2D rehydration buffer [8  M urea, 
2 M thiourea, 2% CHAPS, 65 mM dithiothreitol (DTT), 
and 0.5% ampholyte pH 4–7 or 3–10] were added on to 
the EC monolayer and cells scraped and collected. IE/
EC complexes are most likely to be membrane bound 
protein and cell-surface molecules, therefore, for native 
complexes analysis, lysis of IE was stopped by adding 
9 ml native washing buffer (0.33 M sorbitol, 50 mM bis–
tris pH 7.0), the cells were scraped, collected and washed 
three times. The pellet containing potential intact com-
plexes was further extracted with detergent or diluted in 
protein immunoprecipitation buffer for further analysis.
Two‑dimensional electrophoresis
Samples prepared from co-culture were solubilized in 2D 
rehydration buffer, vortexed, sonicated on ice 10 times 
for 5 s followed by centrifugation at 15,000×g for 10 min, 
and the supernatant was then subjected to 2D electro-
phoresis. 150  µg of protein for co-culture samples was 
loaded. The iso-electric focusing (IEF) was performed 
with pre-cast immobiline Dry-strip gels using IPG-phor 
IEF Unit (Amersham). The running programme con-
sists of 10  h for 30  V, 40  min for 200  V, 1  h for 500  V, 
4  h for 2000  V and finally 8  h for 8000  V. The voltage 
was increased gradually until a total of 80,000  vh was 
reached. The focused strips were equilibrated in 10  ml 
equilibration solution (50  mM tris–HCl, pH 6.8, 6  M 
urea, 30% glycerol, 2% SDS) with reducing agent of 1% 
DTT for 10  min, and 10  ml equilibration solution with 
4.5% iodoacetamide for another 10 min. The strips were 
then washed twice briefly with 1× SDS gel running buffer 
and loaded on 10% or 12.5% SDS-PAGE gels for second 
dimension separation. The gels were usually run over-
night using a Laemmli buffer system [22].
1D Blue‑Native (BN) gel electrophoresis
Blue-Native gels were prepared according to Schag-
ger et  al. [14] with slight modifications. The membrane 
fraction from co-culture experiments was collected 
as described above (insoluble pellet of 0.33  M sorbi-
tol/50  mM bis–tris-HCl, pH 7.0) and extracted using 
25  mM bis–tris-HCl, pH 7.0 with 2% digitonin in 20% 
(w/v) glycerol, for 60  min on ice with agitation. Insolu-
ble material was removed by centrifugation at 18,000×g 
for 30 min. The soluble part was mixed in 10 to 1 ratio 
with BN gel sample buffer (100  mM bis–tris-HCl, pH 
7.0/0.5 M 6-amino-n-caproic acid/30% sucrose/5% Serva 
Blue G) and applied to 0.75 mm thick/5–15% BN gradi-
ent gels in an Amersham Hoefer SE 600 vertical unit. 
Gels were run at a constant voltage of 150  V at 10  °C 
for approximately 8  h. The cathode buffer (50  mM tri-
cine/15 mM bis–tris) was exchanged with buffer lacking 
dye after the top 1/3–1/2 of the gel was covered with dye 
(~ 2 h). Gels for immunoblotting were incubated in trans-
fer buffer with 0.1% SDS for 10 min at room temperature 
before transferring.
Western blot on 1D Blue‑Native (BN) gel
Blue-Native gels were prepared and run as described 
above. The duplicated gel was incubated in transfer 
buffer (25  mM Tris-base, 190  mM glycine, 20% metha-
nol) with 0.1% SDS for 10 min at room temperature, then 
electrophoretically transferred to nitrocellulose, and the 
membranes were blocked by overnight incubation in 5% 
skim-milk in Tris/saline/Tween (TST: 0.01  M Tris, pH 
8.5, 0.15  M sodium chloride, 0.1% Tween 20). The blot 
was incubated with non-adhesion blocking mouse mono-
clonal antibody to ICAM-1 (GP89-14, gift from Prof Judy 
Johnson) (1:2000) and rabbit antisera to HSP60 (1:5000) 
dilution in TST. The secondary antibodies goat anti-
mouse or rabbit IgG (heavy + light chain) horseradish 
peroxidase conjugate (Nordic, 1:3000) were used to local-
ize antibody-antigen complexes. Blots were developed 
using ECL Western blot detection reagent (GE Health-
care, UK).
In gel digestion for nano‑flow LC/MS/MS
A set of intact complexes from co-culture were produced 
by separation on BN gels and identified by mass spec-
trometry. Some specific bands were also identified by 
immunoblot using anti-ICAM-1 and HSP60 antibodies 
(see Additional file 1). The sub-proteomes were achieved 
by excising protein bands from the BN gel according to 
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the diagram in Fig.  2. The bands were excised from the 
same gel, to ensure consistent running conditions, put 
into an Eppendorf Ultra Pure 1.5 ml centrifuge tube and 
then cut into 1  mm3 cubes and rinsed twice in 200  µl 
MilliQ water for 15 min. The gel slices were dehydrated 
by the addition of 100 µl of 50% (v/v) acetonitrile/water, 
incubated at room temperature for 10  min which was 
then removed. 100 µl of ammonium bicarbonate (50 mM) 
was then added to each sample and incubated again at 
room temperature for 10 min. These last two steps were 
repeated. After removal of the ammonium bicarbonate, 
10  µl of Promega (Southampton, UK) sequence grade 
trypsin (10  µg/ml in 50  mM ammonium bicarbonate) 
was then added to the gel fragments and incubated at 
37  °C for 18  h (overnight), after which the supernatant 
was removed and kept. 20 µl of 70% acetonitrile (v/v in 
water) was added to the gel and incubated for 30 min at 
room temperature. The supernatant was then removed 
and pooled with the previous supernatant. The combined 
supernatant was dried in a speed-vac and resuspended in 
12 µl of 0.1% formic acid.
Mass spectrometry and database searching
Nanoflow LC–MS/MS analysis and database searching 
were according to previously described methods [23, 24] 
using liquid chromatography separation (Ultimate 3000 
LC, DIONEX) coupled to an LCQ Deca XP plus Ion-
trap Mass Spectrometer (Thermo Finnigan, Palo Alto, 
CA USA). The samples were initially desalted and con-
centrated on a C18 peptide trap. The peptides were then 
separated on a C18 PepMap nanocolumn (3  μl 100  Å, 
Dionex). Following sample injection, peptides were 
eluted with a 50 min gradient of 0–50% acetonitrile at a 
flow rate of 0.3 μl/min. The mass spectrometer was oper-
ated on a data dependent ‘Triple play’ mode where the 
three most intense ions in the full scan were subjected to 
a zoom scan followed by MS/MS. MS analysis was per-
formed on an LCQ Deca XP plus Ion-trap Mass Spec-
trometer using Xcalibur (version 2.1) software (Thermo 
Scientific, UK). Ions were scanned between 350 and 2000 
m/z in positive polarity mode. The ion-trap operated 
with CID MS/MS (with wide band activation) on the 20 
most intense ions.
Recent work from other groups has used combined 
human/parasite databases [25, 26], therefore the raw data 
from the BN gel slices were searched using the appropri-
ate combinations of the Uniprot human protein sequence 
database (downloaded 17.7.17) combined with the appro-
priate P. falciparum (release 33, June 2017) 3D7 or ItG 
annotated protein sequences. Proteins were identified 
using Thermo Proteome Discoverer v 1.4 by combin-
ing Sequest HT and Mascot searches in a single work-
flow with the following parameters (all other values at 
default). Precursor mass tolerance 0.5 Da; Fragment mass 
tolerance 0.3 Da; N-terminal acetylation and oxidation of 
methionine as variable modifications; carbamidomethyl 
cysteine as fixed modifications; full trypsin digestion with 
max missed cleavages 2. Search engine results were com-
bined and subjected to target decoy PSM validation oper-
ating a strict FDR significance threshold of 1%. The mass 
spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE partner 
repository with the dataset identifier PXD009154.
Bioinformatics
The goal for the informatics approach was to derive a list 
of proteins unique to bands analysed with the binding 
parasite line, that were not seen in a similar location (the 
corresponding band plus the bands either side) in the 
non-binding sample. Two approaches were used to com-
pare the protein lists produced by the MS/MS analysis. 
Proteins IDs were manually inspected to identify matches 
between corresponding bands in the binding (ItG) and 
non-binding (3D7) samples, by comparing an ItG band to 
the corresponding band in the 3D7 track as well as the 
two adjacent 3D7 bands. This included direct matches 
of sequence identifiers as well as clear overlaps in the 
annotation (e.g. different entries for the same or very 
similar proteins). For the human samples this was rela-
tively straightforward due to the depth of the annotation 
but for the parasite entries the lack of annotation of the 
IT genome was a challenge, as was how to handle mem-
bers of gene families, such as PfEMP1. For the latter, any 
overlapping ID of PfEMP1 or EMP1 was scored as being 
a ‘match’ and removed from the final list, although this 
may subtract real differential hits for this protein.
To provide an unbiased computer approach to pro-
tein identification, the composition of each of the 32 gel 
bands excised from the binding isolate was compared 
with the equivalent band, plus adjacent bands, from the 
non-binding isolate before further processing to provide 
a non-redundant list of proteins identified in each bind-
ing isolate gel band. Briefly, accession numbers in each 
band from the binding isolate  (B1–32) were compared 
with a merged file containing accession numbers from an 
equivalent overlapping window of bands from the non-
binders group (comprising each equivalent band from 
the non-binding isolate  [NB1–32] and two adjacent thin 
bands i.e.  NB+1 and  NB−1). In a refinement to this strat-
egy, the output of this initial comparison (a set of protein 
sequences unique to each NB band), was compared (by 
BLASTP) to protein sequences contained within each of 
the merged files to further exclude related sequences on 
the basis of a shared level of identity [Human data: > 65% 
over a min 100aa overlap in almost all cases; two matches 
of 100% over 80aa were also accepted as identity; Parasite 
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data: > 40% over a minimum of 100aa (the lower limit 
allows for variation between the ItG and 3D7 genomes)]. 
The final output was a non-redundant set of proteins 
detected in each band from the binding isolate. Further 
details of the technical specifications of this pipeline are 
available on request.
Functional analyses were carried out on the final lists 
for parasite and human proteins, but only the latter 
showed any coherent structure. Ninety-five non-redun-
dant protein sequences identified in binding experi-
ments were annotated by BLASTP and Interpro using 
Blast2GO v4.1.9 against preformatted NCBI nr protein 
database volume 68 (14.6.17) [default parameters except 
Blast E-value 1 × 10−5; Max hits 20] prior to mapping 
and annotation using default parameters. GO annota-
tions for molecular function are displayed as a combined 
graph (sequence filter 15; Nodescore filter 35; Nodescore 
alpha 2). Decoration by Nodescore highlights significant 
contributions from annotations associated with bind-
ing including the formation of complexes, dimers and 
cytoskeletal protein binding (see Additional file 2).
Results
The first phase of this investigation was to examine the 
profiles of parasite proteins potentially involved in adhe-
sion to endothelium. To investigate this, metabolically 
labelled IE were used in the co-culture system where 
intact trophozoites of ItG (adherent) and C24 (non-
adherent) strains were exposed to HUVEC. Figure  1 
shows the 2D gel IE-fraction binding profiles and while 
ItG shows several proteins revealed by this approach, 
C24 shows fewer protein spots than ItG due to the very 
much reduced binding to HUVEC demonstrated by 
this parasite line. This is in line with the binding pheno-
types of the two parasite variants, as ItG is able to bind 
to ICAM-1, which is expressed at high levels on TNF-
activated HUVEC, whereas C24 and the 3D7 line also 
used in this study do not bind to ICAM-1 but show adhe-
sion to CD36, which is not expressed on HUVEC. This 
approach gives a picture of the potential abundance of 
adhesion-dependent proteins but does not provide spe-
cific information about complexes or associations as the 
presence of proteins could be due to being carried along 
in membrane components rather than directly interact-
ing with other host or parasite molecules.
To improve the identification of protein associations/
complexes formed differentially under adherent and 
non-adherent conditions, BN gel separation coupled 
with mass spectrometry was used. Shown in Fig.  2 is a 
Coomassie blue stained BN 1D gel containing samples 
extracted from ItG (adherent) and 3D7 (non-adherent) 
IE co-cultured with HUVEC. As can be seen from this 
figure, the native proteins were separated well in the 
range from 700 to 50  kDa, and showed equal amounts 
Fig. 1 Parasite proteins associated with endothelial binding. Synchronized C24 and ItG parasites grown to mature stage (approximately 25–30 h 
post‑invasion) were enriched by Plasmagel flotation and metabolically labelled using 35S methionine. The labelled IE were used intact in co‑culture 
with confluent TNF‑activated HUVEC cells for 30 min after which unbound IE were removed and proteins prepared from the adherent cells. The 
figure shows autoradiographs of samples run on IEF gels (pH 4–7) followed by 12.5% SDS‑PAGE co‑culture with intact C24 infected erythrocytes 
with HUVEC (left) and intact ItG infected erythrocytes with HUVEC (right). Corresponding gels stained with Coomassie blue were used to ensure 
equivalent loading (data not shown). Scale on left hand side in kDa
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of proteins loaded on each gel. These protein lanes were 
excised into 32 thin bands per lane (Fig. 2) and processed 
separately for identification by LC/MS/MS.
All proteins extracted and separated by this native 
protein method should represent a small pool of com-
plexed (and uncomplexed) proteins in the given sam-
ple. Therefore, a comparison of protein pools was made 
using samples derived from co-culture of HUVEC with 
3D7 and ItG, the expectation being that the 3D7 samples 
would provide ‘background’ identifications that could be 
subtracted from the ItG samples, which should include 
associations/complexes formed under adherent condi-
tions. The MS identification data were analysed based on 
the position in the gel in Fig. 2 and those identified in the 
ItG sample were checked for the presence of identical or 
similar IDs in the corresponding and flanking 3D7 bands, 
both manually and using a computer-based approach. 
After subtraction based on ID matching and BLAST 
searches, proteins remaining (parasite and human) were 
considered as being in potential protein complexes that 
differ between binding and non-binding parasites. The 
full lists of identified human and parasite proteins are 
shown in Additional files 3 and 4, respectively and the 
final list post-subtraction, with parasite and host pro-
teins shown side by side, in Table 1. Specific candidates 
are discussed in more detail below, but briefly from the 
human EC component there were a significant number 
of cytoskeleton proteins, some with signalling functions 
(ezrin; girdin; tubulin) as well as a smaller number of 
specific signalling molecules (tyrosine-phosphorylated 
regulated kinase 2). On the parasite side, PfEMP1 was 
only seen in the ItG samples in bands 6 and 14. Some 
parasite-derived signalling proteins were also seen. While 
the subtraction process did remove some background, 
some non-specific hits were retained, seen in the recov-
ery, for example, of a number of mitochondrial and ribo-
somal proteins and several keratins (most likely due to 
contamination from human epidermis during sample 
preparation).
To understand more about the potential complex 
formed around the ICAM-1/PfEMP1 interaction, immu-
noblot following native gel electrophoresis was per-
formed using a non-adhesion blocking monoclonal 
antibody to human ICAM-1. The native ICAM-1-recog-
nized region migrated to the position of approximately 
400  kDa in the adhesion proficient ItG sample (Addi-
tional file  1: Figure S1), which ran only slightly higher 
in its migration than in the non-binding 3D7 sample. 
The denatured form of ICAM-1 in SDS-PAGE migrates 
at approximately 90–95  kDa depending on the level of 
glycosylation.
The position of the ICAM-1 complexes by immunoblot 
was similar to the bands identified in the BN-gel for 3D7- 
and ItG-HUVEC (bands 13–15) samples (Additional 
file 3: Table S1). The lack of identification of ICAM-1 in 
the post-filter human samples in the comparative BN gel 
analysis described above (Table 1) is probably due to the 
relatively close co-migration seen on BN gels and sug-
gests that changes in this complex would not be picked 
up with this system, however, other cytoadherence-
linked protein associations may still be identified.
Interestingly PfEMP1 was identified only in the ItG-
HUVEC co-culture sample and not the non-adherent 
(3D7) sample, at bands 6 and 14 in the BN gel, with the 
higher molecular weight band potentially representing 
an adhesion-specific PfEMP1 complex. However, neither 
of these PfEMP1 matched the expected major variant for 
ItG (ITvar16).
Fig. 2 One‑dimensional Blue‑Native gel electrophoresis of 
co‑cultured samples. One‑dimensional Blue‑Native (BN) gel 
electrophoresis was performed on samples prepared to retain 
protein complexes from co‑culture of non‑adherent (3D7‑HUVEC) 
and adherent (ItG‑HUVEC) parasite lines and TNF‑activated HUVEC. 
The figure shows the Coomassie blue stained 1D BN gel and a 
schematic of the position of slicing bands from 1D BN gel for protein 
identification
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Table 1 Proteins identified through differential BN gel analysis
Human Parasite
Band 1 P50990 T‑complex protein 1 subunit theta PFIT_0712500 Calmodulin
P23396 40S ribosomal protein S3 PFIT_1211500 Ca2+‑dependent ATPase
Q13409 Cytoplasmic dynein 1 intermediate chain 2
Band 2 P04264 Keratin, type II cytoskeletal 1 PFIT_0216100 Autophagy‑related protein 11, putative
P13645 Keratin, type I cytoskeletal 10  PFIT_1321500 Translation initiation factor EIF‑2B subunit related
P17661 Desmin
P35527 Keratin, type I cytoskeletal 9
A6NNL0 NUT family member 2B
Band 3 P17661 Desmin PFIT_1235400 ATP synthase subunit beta, mitochondrial
P13645 Keratin, type I cytoskeletal 10 PFIT_0703500 E3 ubiquitin‑protein ligase
Q92630 Dual specificity tyrosine‑phosphorylation‑regulated 
kinase 2
PFIT_1247800 Unknown function
Q92545 Transmembrane protein 131 PFIT_0303600 Lipoamide acyltransferase component of branched‑
chain alpha‑keto acid dehydrogenase complex
Q86YH2 Zinc finger protein 280B
Band 4 P04075 Fructose‑bisphosphate aldolase A PFIT_1235400 ATP synthase subunit beta, mitochondrial
Q14203 Dynactin subunit 1 PFIT_1403800 Unknown function—RBP homology
P21796 Voltage‑dependent anion‑selective channel protein 1 PFIT_0529300 Acyl‑CoA synthetase
Q13242 Serine/arginine‑rich splicing factor 9 PFIT_1032700 Unknown function
Band 5 P21796 Voltage‑dependent anion‑selective channel protein 1 PFIT_1415500 Atypical protein kinase, ABC‑1 family, putative
Q8IVL1 Neuron navigator 2 PFIT_1025500 Unknown function
Q9GZL7 Ribosome biogenesis protein WDR12
Band 6 A5A3E0 POTE ankyrin domain family member F PFIT_0712500 Calmodulin, putative
P40939 Trifunctional enzyme subunit alpha, mitochondrial PFIT_0533600 Unknown function—Ser/Thr kinase/Arginase
Q6ZSB9 Zinc finger and BTB domain‑containing protein 49 PFIT_1415500 Atypical protein kinase, ABC‑1 family, putative
PFIT_1017700 Serine/threonine protein phosphatase 8, putative
PFIT_1400200 Erythrocyte membrane protein 1, PfEMP1
Band 7 P00915 Carbonic anhydrase 1 PFIT_0514400 Aspartate–tRNA ligase, putative
P35527 Keratin, type I cytoskeletal 9
Q96T23 Remodeling and spacing factor 1
Q008S8 Epithelial cell‑transforming sequence 2 oncogene‑like
O43506 Disintegrin and metalloproteinase domain‑containing 
protein 20
Q8TE49 OTU domain‑containing protein 7A
Band 8 P00915 Carbonic anhydrase 1 PFIT_1022600 Dynein heavy chain, putative
P04075 Fructose‑bisphosphate aldolase A PFIT_0421800 Unknown function—Arginase?
P04264 Keratin, type II cytoskeletal 1
P15311 Ezrin
Band 9 P00915 Carbonic anhydrase 1 PFIT_1006100 Unknown function
P04075 Fructose‑bisphosphate aldolase A PFIT_0809500 Kinesin‑like protein, putative
P14406 Cytochrome c oxidase subunit 7A2, mitochondrial
P01138 Beta‑nerve growth factor
Band 10 P00915 Carbonic anhydrase 1 PFIT_1006100 Unknown function
P60709 Actin, cytoplasmic 1 PFIT_0533600 Unknown function—Ser/Thr kinase/Arginase
Q12849 G‑rich sequence factor 1 PFIT_1135000 Unknown function
Q13277 Syntaxin‑3 PFIT_1365300 Unknown function—Arginase?
PFIT_1033700 Thioredoxin‑like associated protein 2, putative
Band 11 Q06830 Peroxiredoxin‑1 PFIT_1364900 Ubiquitin‑60S ribosomal protein L40
P62979 Ubiquitin‑40S ribosomal protein S27a PFIT_1415500 Atypical protein kinase, ABC‑1 family, putative
P35030 Trypsin‑3 PFIT_0516200 Cation‑transporting ATPase 1
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Table 1 (continued)
Human Parasite
Q96RS6 NudC domain‑containing protein 1 PFIT_1310300 Unknown function—nuclear structural protein?
Q3V6T2 Girdin PFIT_1359000 Unknown function—Pf‑SET1 homology
Q15075 Early endosome antigen 1
Q7Z429 Protein lifeguard 1
Band 12 P13645 Keratin, type I cytoskeletal 10 PFIT_1201800 Unknown function—protein kinase?
P35908 Keratin, type II cytoskeletal 2 epidermal PFIT_1022600 Dynein heavy chain, putative
Q8TCT9 Minor histocompatibility antigen H13
Q13277 Syntaxin‑3
Band 13 P00338 l‑lactate dehydrogenase A chain PFIT_1222000 Endoplasmin, putative
P32119 Peroxiredoxin‑2 PFIT_0709100 Unknown function
Q9UFH2 Dynein heavy chain 17, axonemal
P27824 Calnexin
P04264 Keratin, type II cytoskeletal 1
Band 14 P14618 Pyruvate kinase PKM PFIT_bin02200 A4varTres‑erythrocyte membrane protein 1, putative
Q13277 Syntaxin‑3 PFIT_1033700 Thioredoxin‑like associated protein 2, putative
Band 15 Q9Y4L1 Hypoxia up‑regulated protein 1 PFIT_0821800 Heat shock protein 70
P11142 Heat shock cognate 71 kDa protein PFIT_1222000 Endoplasmin, putative
P13645 Keratin, type I cytoskeletal 10
Q6UXS9 Inactive caspase‑12
Q13277 Syntaxin‑3
Q9HD43 Receptor‑type tyrosine‑protein phosphatase H
Band 16 Q5T0J7 Testis‑expressed protein 35
Band 17 Q9Y250 Leucine zipper putative tumor suppressor 1 PFIT_0312000 E3 ubiquitin‑protein ligase, putative
P32119 Peroxiredoxin‑2
Band 18 P37802 Transgelin‑2 PFIT_0821800 Heat shock protein 70
P16520 Guanine nucleotide‑binding protein G(I)/G(S)/G(T) 
subunit beta‑3
PFIT_1015800 Glycophorin binding protein
P61604 10 kDa heat shock protein, mitochondrial PFIT_1364900 Ubiquitin‑60S ribosomal protein L40
P40926 Malate dehydrogenase, mitochondrial PFIT_1424700 Unknown function—Arginase?
Q96KP4 Cytosolic non‑specific dipeptidase PFIT_1366800 Secreted ookinete protein, putative—fibrinogen 
receptor homology
P62979 Ubiquitin‑40S ribosomal protein S27a
Q6ZU64 Cilia‑ and flagella‑associated protein 65
Band 19 Q99536 Synaptic vesicle membrane protein VAT‑1 homolog PFIT_0108600 Selenocysteine‑specific elongation factor selB homo‑
logue, putative
A6NCI8 Uncharacterized protein C2orf78 PFIT_1108600 Transcription factor with AP2 domain(s)
P30485 HLA class I histocompatibility antigen, B‑47 alpha 
chain
Band 20 P38646 Stress‑70 protein, mitochondrial PFIT_1324100 l‑lactate dehydrogenase
P35527 Keratin, type I cytoskeletal 9 PFIT_1364900 Ubiquitin‑60S ribosomal protein L40
Q9HDC9 Adipocyte plasma membrane‑associated protein PFIT_1246400 Actin I
Q8IXQ4 GPALPP motifs‑containing protein 1 PFIT_0821800 Heat shock protein 70
Q8TF05 Serine/threonine‑protein phosphatase 4 regulatory 
subunit 1
PFIT_1356100 Elongation factor 1‑alpha
Q9Y3P9 Rab GTPase‑activating protein 1 PFIT_1416700 Serine C‑palmitoyltransferase, putative
Q9H0V9 VIP36‑like protein PFIT_0930800 Peptidyl‑prolyl cis–trans isomerase
Q9NR99 Matrix‑remodeling‑associated protein 5 PFIT_0304700 Unknown function
Band 21 Q15084 Protein disulfide‑isomerase A6 PFIT_0834600 Heat shock protein 70
P38646 Stress‑70 protein, mitochondrial PFIT_1324100 l‑lactate dehydrogenase
Q96PU4 E3 ubiquitin‑protein ligase UHRF2
P11465 Pregnancy‑specific beta‑1‑glycoprotein 2
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Table 1 (continued)
Human Parasite
Q9H6F5 Coiled‑coil domain‑containing protein 86
Band 22 Q9HDC9 Adipocyte plasma membrane‑associated protein PFIT_0707300 Heat shock protein 90
Q8TF05 Serine/threonine‑protein phosphatase 4 regulatory 
subunit 1
PFIT_0533600 Unknown function—Ser/Thr kinase? Arginase?
Q9Y6N3 Calcium‑activated chloride channel regulator family 
member 3
PFIT_0821800 Heat shock protein 70
Q6ZTB9 Putative zinc finger protein 833 PFIT_0910700 DNA repair protein REV1, putative
PFIT_1246400 Actin I
Band 23 P30101 Protein disulfide‑isomerase A3 PFIT_1246400 Actin I
P32119 Peroxiredoxin‑2 PFIT_0913400 Unknown function—histone modification?
PFIT_1206600 Unknown function
PFIT_0513300 Unknown function—RBP homology/histone modifica‑
tion?
PFIT_0410400 Unknown function—Ser/Thr kinase?
Band 24 P51148 Ras‑related protein Rab‑5C PFIT_0617200 60S ribosomal protein L27a, putative
Q9P2D7 Dynein heavy chain 1, axonemal PFIT_0902700 Serine/threonine protein kinase, FIKK family
Q9UBM7 7‑dehydrocholesterol reductase PFIT_1359000 Unknown function—Pf‑SET1 homology
Q8TF05 Serine/threonine‑protein phosphatase 4 regulatory 
subunit 1
PFIT_1252300 Rhoptry neck protein 3
Q96PU4 E3 ubiquitin‑protein ligase UHRF2
P02750 Leucine‑rich alpha‑2‑glycoprotein
Band 25 P35030 Trypsin‑3 PFIT_1356100 Elongation factor 1‑alpha
O95057 GTP‑binding protein Di‑Ras1 PFIT_0821800 Heat shock protein 70
PFIT_1017700 Serine/threonine protein phosphatase 8, putative
PFIT_1246900 Unknown function—Ser/Thr kinase?
PFIT_0700800 Unknown function—Ser/Thr kinase?
Band 26 P35527 Keratin, type I cytoskeletal 9
O43852 Calumenin
P35030 Trypsin‑3
Band 27 P27797 Calreticulin PFIT_1319900 Unknown function—Ser/Thr kinase?
Q6NXR4 TELO2‑interacting protein 2
O43572 A‑kinase anchor protein 10, mitochondrial
O95696 Bromodomain‑containing protein 1
Q8IWY8 Zinc finger and SCAN domain‑containing protein 29
P55786 Puromycin‑sensitive aminopeptidase
Q8TF05 Serine/threonine‑protein phosphatase 4 regulatory 
subunit 1
Band 28 P68371 Tubulin beta‑4B chain PFIT_1246400 Actin I
P27797 Calreticulin PFIT_1008200 Tubulin beta chain
O95057 GTP‑binding protein Di‑Ras1 PFIT_0533600 Unknown function—Ser/Thr kinase/Arginase?
PFIT_1469200 Unknown function – Ser/Thr kinase?
PFIT_0317700 CPSF (cleavage and polyadenylation specific factor), 
subunit A, putative
PFIT_0709100 Unknown function
PFIT_1350900 Inner membrane complex protein 1f, putative
Band 29 Q8IUR0 Trafficking protein particle complex subunit 5 PFIT_0930800 peptidyl‑prolyl cis–trans isomerase
P68371 Tubulin beta‑4B chain PFIT_0628900 CPW‑WPC family protein
Q66K74 Microtubule‑associated protein 1S PFIT_1475300 Unknown function
Q9H013 Disintegrin and metalloproteinase domain‑containing 
protein 19
PFIT_1246400 Actin I
Band 30 P37802 Transgelin‑2 PFIT_1246400 Actin I
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Combined human and parasite databases have been 
used often for global searches using complex mixtures of 
proteins. Even though this work uses relatively restricted 
protein pools, this approach was taken using the data 
generated from the BN gel slices. Key to the differen-
tial analysis of the biological samples described in this 
paper is retaining their positional information in the BN 
gel, as alterations in migration could indicate differential 
complex formation, whereas a search using data com-
bined from all gel slices from the 3D7-HUVEC and ItG-
HUVEC samples would not incorporate this property.
Discussion
An approach employing a combination of 1D BN gel 
electrophoresis combined with MS/MS analysis was used 
to identify potential candidates for differential protein 
complex formation. The approach relies on using a com-
parison of samples differing in key biological features (in 
this case cytoadherence to endothelium by comparing 
adherent and non-adherent parasite lines) followed by 
procedures to identify differences between the samples. 
An automated computational approach was validated by 
comparing it to manual curation of the findings, with a 
concordance of 92.5% based on 348 out of 376 concord-
ant bands analysed using the human dataset. This infor-
mation is shown in Additional file 3: Table S1, in which 
proteins remaining after manual curation have been left 
unshaded, rather than in light or dark blue, and computer 
generated unique hits are highlighted in yellow (on the 
sequence identifier). The concurrence of an unshaded 
protein name with a yellow highlighted sequence iden-
tifier or a shaded protein name with a non-highlighted 
identifier indicates agreement between the manual and 
automated methods of subtraction. The comparative 
approach removes a significant amount of background, 
although clearly several ‘contaminants’ remain and are 
retained in the differentially recognised protein set for 
completeness. This is a relatively simple approach for 
candidate identification that would be relevant for a wide 
range of biological questions where standard global sub-
tractive approaches may not reveal differential complex 
formation.
A finding in this work is that actin and actin-binding 
proteins were abundantly located in many complexes in 
both the human and parasite fractions. Given the mem-
brane source of the samples this is not a surprise, how-
ever the differential distribution of this class of proteins 
in the adherent and non-adherent samples suggests that 
cytoadherence alters the cytoskeleton/microtubule net-
work. For example, the parasite actin-1 is seen exten-
sively in the post-subtraction list for parasite proteins 
in ItG-HUVEC (see Additional files 1, 2, 3 and 4 for full 
protein lists). An aspect of the actin-containing cytoskel-
eton is that in human systems changes in this structure 
can be harnessed to provide a platform for signaling. For 
example, ICAM-1 dependent signaling requires the short 
cytoplasmic domain of ICAM-1 interacting with F-actin, 
such that the actin cytoskeleton provides the signal trans-
duction framework. In other systems ICAM-1 associates 
with the actin-containing cytoskeleton and this interac-
tion leads to modification of the cell surface distribu-
tion of ICAM-1 [27]. Previous work has also shown that 
PfEMP-1 expression varies between parasite lines, which 
results in changes in their avidity for EC receptors and 
induces, for example, different levels of ICAM-1 depend-
ent signalling in the EC they bind to [20].
Apoptosis is postulated to be a way in which cytoad-
herence can contribute to causing disease through reduc-
tion in EC barrier integrity. The binding of IE to brain 
EC has been reported to induce endothelial cell apop-
tosis, for example, Pino et al. [28] have demonstrated IE 
modulation of the expression of endothelial apoptosis-
related genes. Toure et  al. subsequently showed that 
some clinical isolates could induce EC apoptosis [29] 
and the presence of apoptotic cells might upregulate the 
expression of cellular adhesion molecules, resulting in 
Table 1 (continued)
Human Parasite
P09417 Dihydropteridine reductase PFIT_1133900 Unknown function
P17568 NADH dehydrogenase [ubiquinone] 1 beta subcom‑
plex subunit 7
PFIT_1350900 Inner membrane complex protein 1f, putative
P19827 Inter‑alpha‑trypsin inhibitor heavy chain H1 PFIT_1329100 Unknown function—Tyr kinase/Ser/Thr kinase?
Band 31 PFIT_0621900 Chorismate synthase
Band 32 Q13698 Voltage‑dependent L‑type calcium channel subunit 
alpha‑1S
PFIT_0821100 14‑3‑3 protein
Q8NBS9 Thioredoxin domain‑containing protein 5 PFIT_1123800 Dynein heavy chain, putative
PFIT_1229500 Myosin D
Summary table showing differentially identified proteins between binding and non-binding parasite lines from the BN gel slices for human and parasite (IT) 
components. The sequence identifier and a short description are given for each protein
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hyper-adhesiveness, leading to a greater accumulation 
of IE and subsequent increase in EC apoptosis [30]. In 
this study, identified proteins were also identified that 
are implicated in apoptosis such as Transgelin-2 and 
Thioredoxin domain-containing protein 5. Transgelin-2 
is an actin-binding protein expressed in endothelial cells 
responsible partly for maintenance of vascular perme-
ability [31] and associated with modulation of apopto-
sis [32, 33]. Variation in the induction of apoptosis by 
malaria parasites has been reported previously [29, 34] 
and it is possible that these findings are related to this 
potentially pathological or protective phenotype, with the 
latter vascular protective behaviour being associated with 
the differential identification of the inhibitor of apoptosis, 
thioredoxin domain-containing protein 5 [35].
Several groups have identified signalling pathways that 
are activated in host endothelium by cytoadherence, and 
this is reflected in the identification of classical kinases 
such as dual specificity tyrosine-phosphorylation-regu-
lated kinase 2, as well as structural signalling molecules 
such as ezrin that act via the actin cytoskeleton and may 
be involved in ICAM-1 induced signalling [36]. The 
malaria parasite has an extensive signalling family of 
proteins [37] and has recently been shown to be able to 
respond to external stimuli [38, 39], although not yet to 
cytoadherence. Several signalling proteins were identi-
fied in this study from different kinase groups (e.g. FIKK) 
that could be taken forward as candidates for adhesion-
related signalling in the parasite, linked to phenotypes 
such as antigenic switching and gametocytogenesis. Of 
interest is a putative parasite serine/threonine protein 
phosphatase eight member, co-localised with PfEMP1 
(band 6), which belongs to a family of phosphatases 
involved in external cellular communication via regulat-
ing exocytosis [40], and the presence of the host cytoskel-
etal associated intracellular signalling molecule POTE 
ankyrin domain family F also in band 6, which may indi-
cate a potential pathway for PfEMP1-mediated adhesion 
to influence the behaviour of the adhered endothelial cell.
An interesting new finding was the presence of Girdin 
in the ItG sample (band 11). The Girdin family of signal-
ling proteins have been associated with Akt and, poten-
tially more interesting in this context, the Wnt pathway 
[41]. The latter signalling pathway is involved in control-
ling endothelial barrier function and has been implicated 
recently in malaria parasite/endothelium co-culture stud-
ies [42]. Several other candidates have potential matches 
to pathways that may be implicated in endothelial pro-
cesses linked to malaria pathology such as Peroxire-
doxin-2 (anti-oxidant), Syntaxin-3 (vesicle formation), 
Rab GTPase-activating protein (regulation of exocyto-
sis), Trypsin-3 (clotting cascade), Calreticulin (stimulates 
NO production) and ADAM19 (cell adhesion and signal 
transduction).
Conclusions
In summary, an approach was used for the discovery of 
proteins involved in complexes to identify those poten-
tially associated with malaria cytoadherence. Further 
work will be needed to confirm their participation in 
specific complexes and the minimal peptide identifica-
tion (n = 1) seen with several samples suggests that the 
findings need to be treated with caution, but many of the 
biological roles for these candidates are consistent with 
phenotypes associated with adhesion-linked changes in 
malaria infection.
Additional files
Additional file 1. One‑dimensional blue‑native gel electrophoresis 
combined with Immuno‑blot analysis of co‑culture complexes. Bis‑tris‑
insoluble, Digitonin extracted co‑culture proteins were separated by 
1D BN‑PAGE, transferred to nitrocellulose membranes and probed with 
antibody to human ICAM‑1 and HSP60 (control). Sample lanes: 1 ‑ co‑
culture of HUVEC with uninfected erythrocytes; 2 ‑ co‑culture of HUVEC 
with 3D7 infected erythrocytes; 3 ‑ co‑culture of HUVEC with ItG‑infected 
erythrocytes.
Additional file 2. Combined graph of human proteins annotated by 
GO molecular function terms. Non‑redundant protein sequences (30) 
identified in binding experiments were BLAST and Interpro annotated 
using Blast2GO v4.0.7 against preformatted NCBI nr database volume 41 
(21.11.15) [default parameters except Blast E‑value 1×10−5; Max hits 20] 
prior to mapping and annotation using default parameters. GO annota‑
tions for molecular function are displayed as a combined graph (sequence 
filter 15; Nodescore filter 35; Nodescore alpha 2). Decoration by Nodescore 
highlights significant contributions from annotations associated with 
binding including the formation of complexes, dimers and cytoskeletal 
protein binding.
Additional file 3. List of human proteins identified in each band for the 
3D7‑HUVEC and ItG‑HUVEC samples. Dark and light blue shaded IDs in 
the ItG column show common bands also seen in relevant 3D7 bands 
removed by manual curation. Yellow highlighted sequence identifiers 
represent bands identified by the computer pipeline as being unique to 
the ItG‑HUVEC sample when compared with the corresponding band and 
one band either side. Numbers of peptides identified for each protein are 
indicated.
Additional file 4. List of parasite proteins identified in each band for the 
3D7‑HUVEC and ItG‑HUVEC samples. Dark and light blue shaded IDs in 
the ItG column show common bands also seen in relevant 3D7 bands 
removed by manual curation. Yellow highlighted sequence identifiers 
represent bands identified by the computer pipeline as being unique to 
the ItG‑HUVEC sample when compared with the corresponding band 
and one band either side. Numbers of peptides identified for each protein 
(often only a single peptide) are indicated, as are potential functions for 
IT proteins (where available). The specific peptides for the PfEMP1 hits are 
indicated in green.
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